SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Saulamanca
Winfastorlose
To: Winfastorlose who wrote (773899)12/16/2022 8:20:15 AM
From: skinowski2 Recommendations  Read Replies (1) of 793617
 
Speaking of gene therapies for CoViD…. This is an excellent review of the new Novavax vaccine which doesn’t involve injections of any genetic material. They do it the old fashioned way - they manufacture a viral protein - and inject it. Methodology has been used for decades. Still not perfect - esp. must be observed for the incidence of myocarditis in young males. There were a few cases in the study.

The review is a few months old, but this guy is probably the best at explaining these things. Sane, measured - and sticks to facts. Many will remember him from previous talks since the early days of CoViD.

Which reminds me - Novavax was originally made to work against the original version of CoViD. But, apparently, it seems to be active enough against the newer variants.

Start from the beginning.

youtu.be
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext